Alan Richard Tall

Alan Richard Tall's AcademicInfluence.com Rankings

Alan Richard Tall

Biology

#3879

World Rank

#5872

Historical Rank

Computational Biology

#46

World Rank

#46

Historical Rank

Molecular Biology

#266

World Rank

#270

Historical Rank

Genetics

#292

World Rank

#345

Historical Rank

biology Degrees

Download Badge

Biology

Alan Richard Tall's Degrees

PhD Genetics Stanford University

Why Is Alan Richard Tall Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Alan Richard Tall's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids (2010) (3485)
Effects of torcetrapib in patients at high risk for coronary events. (2007) (2393)
ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. (2004) (1018)
Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. (2000) (999)
Cholesterol, inflammation and innate immunity (2015) (921)
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. (1997) (872)
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis (2016) (867)
Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. (1990) (857)
Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis (2003) (815)
Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. (2012) (779)
Scavenger Receptor BI Promotes High Density Lipoprotein-mediated Cellular Cholesterol Efflux* (1997) (735)
Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. (1990) (673)
ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation (2010) (629)
Plasma cholesteryl ester transfer protein. (1993) (617)
Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. (1996) (616)
Specific Binding of ApoA-I, Enhanced Cholesterol Efflux, and Altered Plasma Membrane Morphology in Cells Expressing ABC1* (2000) (579)
Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. (2007) (575)
Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. (2010) (538)
HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. (2008) (530)
Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. (2007) (525)
Dysfunctional HDL and atherosclerotic cardiovascular disease (2016) (496)
Plasma high-density lipoproteins. (1978) (486)
Plasma lipid transfer proteins. (1995) (476)
ATP-binding Cassette Transporter A1 (ABCA1) Functions as a Cholesterol Efflux Regulatory Protein* (2001) (473)
Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins (1989) (472)
Evacetrapib and Cardiovascular Outcomes in High‐Risk Vascular Disease (2017) (462)
ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. (2011) (453)
Exome-wide association study of plasma lipids in >300,000 individuals (2017) (428)
Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. (2013) (422)
Increased Inflammatory Gene Expression in ABC Transporter–Deficient Macrophages: Free Cholesterol Accumulation, Increased Signaling via Toll-Like Receptors, and Neutrophil Infiltration of Atherosclerotic Lesions (2008) (411)
Cholesterol efflux pathways and other potential mechanisms involved in the athero‐protective effect of high density lipoproteins (2008) (409)
Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis. (2005) (389)
Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. (1999) (373)
Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. (2000) (373)
Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. (2014) (365)
Triglyceride, high density lipoprotein, and coronary heart disease. (1993) (335)
Decreased Atherosclerosis in Heterozygous Low Density Lipoprotein Receptor-deficient Mice Expressing the Scavenger Receptor BI Transgene* (1999) (335)
Plasma Sphingomyelin Level as a Risk Factor for Coronary Artery Disease (2000) (326)
Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. (1998) (306)
Scavenger Receptor Class B Type I as a Mediator of Cellular Cholesterol Efflux to Lipoproteins and Phospholipid Acceptors* (1998) (304)
Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. (1991) (304)
HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. (2006) (296)
HDL as a target in the treatment of atherosclerotic cardiovascular disease (2005) (294)
Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. (1995) (290)
The failure of torcetrapib: was it the molecule or the mechanism? (2006) (290)
Liver-specific Overexpression of Scavenger Receptor BI Decreases Levels of Very Low Density Lipoprotein ApoB, Low Density Lipoprotein ApoB, and High Density Lipoprotein in Transgenic Mice* (1998) (289)
Hepatic Scavenger Receptor BI Promotes Rapid Clearance of High Density Lipoprotein Free Cholesterol and Its Transport into Bile* (1999) (283)
An overview of reverse cholesterol transport. (1994) (280)
Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. (2006) (273)
The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis? (2012) (262)
Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. (2013) (261)
Interleukin 8 Is Induced by Cholesterol Loading of Macrophages and Expressed by Macrophage Foam Cells in Human Atheroma (*) (1996) (260)
Regulation and Mechanisms of ATP-Binding Cassette Transporter A1-Mediated Cellular Cholesterol Efflux (2003) (255)
High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1 (2007) (255)
High Density Lipoprotein (HDL) Particle Uptake Mediated by Scavenger Receptor Class B Type 1 Results in Selective Sorting of HDL Cholesterol from Protein and Polarized Cholesterol Secretion* (2001) (254)
Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. (1998) (253)
Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins. (1982) (252)
A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. (2003) (250)
Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Macrophages Increases Inflammation and Accelerates Atherosclerosis in Mice (2013) (245)
Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences. (1992) (241)
Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming (2016) (238)
Rat intestine secretes discoid high density lipoprotein. (1978) (236)
Cholesterol Efflux Potential and Antiinflammatory Properties of High-Density Lipoprotein After Treatment With Niacin or Anacetrapib (2010) (236)
Increased CD36 protein as a response to defective insulin signaling in macrophages. (2004) (230)
Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression. (1999) (229)
A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly Published, JLR Papers in Press, February 16, 2004. DOI 10.1194/jlr.M300520-JLR200 (2004) (229)
Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects. (1990) (227)
Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables. (1991) (226)
Regulation and mechanisms of macrophage cholesterol efflux. (2002) (224)
Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways. (2012) (222)
ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet. (2008) (220)
ATP-binding cassette transporters, atherosclerosis, and inflammation. (2014) (219)
Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency (2001) (218)
LXR-Induced Redistribution of ABCG1 to Plasma Membrane in Macrophages Enhances Cholesterol Mass Efflux to HDL (2006) (216)
Inhibition of Cholesteryl Ester Transfer Protein by Torcetrapib Modestly Increases Macrophage Cholesterol Efflux to HDL (2007) (215)
Human intestinal lipoproteins. Studies in chyluric subjects. (1979) (215)
HDL as a target in the treatment of atherosclerotic cardiovascular disease (2005) (211)
Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism. (2012) (209)
Atherosclerosis: Successes, Surprises, and Future Challenges. (2016) (209)
ATP-binding cassette transporter A7 enhances phagocytosis of apoptotic cells and associated ERK signaling in macrophages (2006) (209)
Translation of High-Density Lipoprotein Function Into Clinical Practice: Current Prospects and Future Challenges (2013) (207)
Scavenger Receptor BI (SR-BI) Is Up-regulated in Adrenal Gland in Apolipoprotein A-I and Hepatic Lipase Knock-out Mice as a Response to Depletion of Cholesterol Stores (1996) (204)
Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis. (1985) (192)
Phosphorylation of a Pest Sequence in ABCA1 Promotes Calpain Degradation and Is Reversed by ApoA-I* (2003) (189)
ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. (2001) (188)
Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA. (1991) (187)
ATP-binding Cassette Transporter A7 (ABCA7) Binds Apolipoprotein A-I and Mediates Cellular Phospholipid but Not Cholesterol Efflux* (2003) (187)
Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein. (1987) (186)
Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. (1986) (186)
Preferential ATP-binding Cassette Transporter A1-mediated Cholesterol Efflux from Late Endosomes/Lysosomes* (2001) (184)
Separation of a plasma phospholipid transfer protein from cholesterol ester/phospholipid exchange protein. (1983) (184)
Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption. (1998) (182)
Metabolic fate of chylomicron phospholipids and apoproteins in the rat. (1979) (182)
Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1. (2000) (179)
Decreased Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice Transplanted With Abcg1−/− Bone Marrow (2006) (178)
Expression of Liver X Receptor Target Genes Decreases Cellular Amyloid β Peptide Secretion* (2003) (178)
Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. (1996) (177)
Organization of the human cholesteryl ester transfer protein gene. (1990) (177)
Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice. (2005) (176)
Trials and Tribulations of CETP Inhibitors. (2018) (171)
ATP‐binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain (2008) (171)
Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis (2013) (169)
Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis (2018) (168)
Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies: A Scientific Statement From the American Heart Association. (2017) (166)
ABCA1 and ABCG1 Protect Against Oxidative Stress–Induced Macrophage Apoptosis During Efferocytosis (2010) (165)
Macrophage deficiency of p38alpha MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice. (2009) (165)
Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. (1991) (161)
Exercise training decreases plasma cholesteryl ester transfer protein. (1993) (161)
Transcriptional Profiling Reveals Global Defects in Energy Metabolism, Lipoprotein, and Bile Acid Synthesis and Transport with Reversal by Leptin Treatment in Ob/ob Mouse Liver* (2001) (159)
Residual macrovascular risk in 2013: what have we learned? (2014) (157)
Free Cholesterol Accumulation in Macrophage Membranes Activates Toll-Like Receptors and p38 Mitogen-Activated Protein Kinase and Induces Cathepsin K (2009) (156)
FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis. (2012) (155)
Purification and characterization of a human plasma cholesteryl ester transfer protein. (1987) (155)
Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia. (1998) (154)
Structure and thermodynamic properties of high density lipoprotein recombinants. (1977) (149)
A Mouse Model with Features of Familial Combined Hyperlipidemia (1997) (148)
C-reactive protein reassessed. (2004) (148)
Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies: A Scientific Statement From the American Heart Association. (2017) (146)
The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis (2021) (145)
Body cholesterol removal: role of plasma high-density lipoproteins. (1980) (143)
The Macrophage at the Crossroads of Insulin Resistance and Atherosclerosis (2007) (141)
Regulation of hepatic LDL receptors by mTORC1 and PCSK9 in mice. (2012) (140)
Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice. (1993) (139)
1999 George Lyman Duff memorial lecture: lipid transfer proteins, HDL metabolism, and atherogenesis. (2000) (138)
A dose-response study of the effects of dietary cholesterol on fasting and postprandial lipid and lipoprotein metabolism in healthy young men. (1994) (138)
Defective Phagocytosis of Apoptotic Cells by Macrophages in Atherosclerotic Lesions of ob/ob Mice and Reversal by a Fish Oil Diet (2009) (135)
Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I. (1999) (134)
Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver. (1990) (133)
Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2V617F Mice (2018) (130)
Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover. (1999) (130)
Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit. Effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism. (1989) (130)
Stearoyl-CoA Desaturase Inhibits ATP-binding Cassette Transporter A1-mediated Cholesterol Efflux and Modulates Membrane Domain Structure* (2003) (130)
Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. (1998) (129)
Cholesterol Accumulation in Dendritic Cells Links the Inflammasome to Acquired Immunity. (2017) (127)
Monoclonal antibodies to the Mr 74,000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma. (1988) (125)
Retinoic Acid Receptor-Mediated Induction of ABCA1 in Macrophages (2003) (122)
The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis D.M. is supported by a grant from the Philippe Foundation. Published, JLR Papers in Press, November 20, 2008. (2009) (122)
Tangier disease as a test of the reverse cholesterol transport hypothesis. (2000) (122)
Scavenger Receptor-BI Inhibits ATP-binding Cassette Transporter 1- mediated Cholesterol Efflux in Macrophages* (2000) (122)
Phospholipid transfer protein (PLTP) deficiency reduces brain vitamin E content and increases anxiety in mice. (2005) (121)
Mechanisms of enhancement of cholesteryl ester transfer protein activity by lipolysis. (1985) (121)
An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels. (1992) (121)
Changes in the distribution and composition of plasma high density lipoproteins after ingestion of fat. (1982) (121)
Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. (1993) (120)
Defective HDL particle uptake in ob/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake. (2000) (119)
Plasma sphingomyelin and subclinical atherosclerosis: findings from the multi-ethnic study of atherosclerosis. (2006) (119)
CETP inhibitors to increase HDL cholesterol levels. (2007) (119)
Plasma lipid transfer proteins. (1986) (118)
Thermotropic transitions in rat intestinal plasma membranes studied by differential scanning calorimetry and fluorescence polarization. (1980) (118)
Acid Sphingomyelinase-deficient Macrophages Have Defective Cholesterol Trafficking and Efflux* (2001) (116)
Studies on the structure of low density lipoproteins isolated from Macaca fascicularis fed an atherogenic diet. (1978) (116)
A PEST Deletion Mutant of ABCA1 Shows Impaired Internalization and Defective Cholesterol Efflux from Late Endosomes* (2005) (114)
ATP-binding cassette transporters G 1 and G 4 mediate cellular cholesterol efflux to high-density lipoproteins (2004) (114)
Phospholipid Transfer Protein Deficiency Protects Circulating Lipoproteins from Oxidation Due to the Enhanced Accumulation of Vitamin E* (2002) (112)
The Orphan Nuclear Receptor LRH-1 Potentiates the Sterol-mediated Induction of the Human CETP Gene by Liver X Receptor* 210 (2001) (111)
The Impact of Macrophage Insulin Resistance on Advanced Atherosclerotic Plaque Progression (2010) (109)
Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins. (2000) (107)
Induction of the Phospholipid Transfer Protein Gene Accounts for the High Density Lipoprotein Enlargement in Mice Treated with Fenofibrate* (2001) (107)
Down-regulation of mRNA for the low density lipoprotein receptor in transgenic mice containing the gene for human cholesteryl ester transfer protein. Mechanism to explain accumulation of lipoprotein B particles. (1993) (107)
Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia. (1995) (104)
TNFα induces ABCA1 through NF-κB in macrophages and in phagocytes ingesting apoptotic cells (2006) (101)
Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice. (2012) (101)
ATP-Binding Cassette Transporter G1 and High-Density Lipoprotein Promote Endothelial NO Synthesis Through a Decrease in the Interaction of Caveolin-1 and Endothelial NO Synthase (2010) (100)
Increased concentration of plasma cholesteryl ester transfer protein in nephrotic syndrome: role in dyslipidemia. (1992) (100)
Hypercholesterolemia and reduced HDL-C promote hematopoietic stem cell proliferation and monocytosis: studies in mice and FH children. (2013) (98)
ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes. (1997) (98)
Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model (2001) (97)
Apoprotein A-I synthesis in normal intestinal mucosa and in Tangier disease. (1978) (97)
Increases in dietary cholesterol are associated with modest increases in both LDL and HDL cholesterol in healthy young women. (1995) (97)
Increase in plasma cholesteryl ester transfer protein during probucol treatment. Relation to changes in high density lipoprotein composition. (1991) (96)
Free Cholesterol-loaded Macrophages Are an Abundant Source of Tumor Necrosis Factor-α and Interleukin-6 (2005) (95)
Cholesterol-induced Apoptotic Macrophages Elicit an Inflammatory Response in Phagocytes, Which Is Partially Attenuated by the Mer Receptor* (2006) (94)
Mechanism of the association of HDL3 with endothelial cells, smooth muscle cells, and fibroblasts. Evidence against the role of specific ligand and receptor proteins. (1984) (93)
Deletion of ABCA1 and ABCG1 Impairs Macrophage Migration Because of Increased Rac1 Signaling (2011) (93)
Decreased selective uptake of high density lipoprotein cholesteryl esters in apolipoprotein E knock-out mice. (1999) (91)
Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice. (1995) (91)
Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice. (2009) (90)
Role of a false neurotransmitter, octopamine, in the pathogenesis of hepatic and renal encephalopathy. (1973) (89)
The cellular biology of scavenger receptor class B type I (2001) (88)
The implications of the structure of the bactericidal/permeability-increasing protein on the lipid-transfer function of the cholesteryl ester transfer protein. (1998) (87)
Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma. (1989) (87)
A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels (2017) (86)
Change in lipid profile in celiac disease: beneficial effect of gluten-free diet. (2006) (86)
Disordered haematopoiesis and athero-thrombosis. (2016) (85)
Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency. (1991) (85)
Unmodified low density lipoprotein causes cholesteryl ester accumulation in J774 macrophages. (1985) (84)
Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice (2016) (84)
Solubilisation of phospholipid membranes by human plasma high density lipoproteins (1977) (82)
Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice. (1994) (82)
Forkhead Transcription Factors (FoxOs) Promote Apoptosis of Insulin-Resistant Macrophages During Cholesterol-Induced Endoplasmic Reticulum Stress (2008) (82)
Lipoprotein lipase enhances the cholesteryl ester transfer protein-mediated transfer of cholesteryl esters from high density lipoproteins to very low density lipoproteins. (1984) (81)
Activation of Liver X Receptor Decreases Atherosclerosis in Ldlr−/− Mice in the Absence of ATP-Binding Cassette Transporters A1 and G1 in Myeloid Cells (2014) (80)
Cholesterol in platelet biogenesis and activation. (2016) (80)
Mechanism of cholesteryl ester transfer protein inhibition by a neutralizing monoclonal antibody and mapping of the monoclonal antibody epitope. (1989) (80)
Enrichment of endothelial cell arachidonate by lipid transfer from high density lipoproteins: relationship to prostaglandin I2 synthesis. (1985) (79)
Interaction between unilamellar egg yolk lecithin vesicles and human high density lipoprotein. (1979) (78)
Plasma cholesteryl ester transfer protein and high‐density lipoproteins: new insights from molecular genetic studies (1995) (77)
Conformational and thermodynamic properties of apo A-1 of human plasma high density lipoproteins. (1976) (77)
Increased HDL Cholesterol and ApoA-I in Humans and Mice Treated With a Novel SR-BI Inhibitor (2009) (76)
Interleukin-3/Granulocyte Macrophage Colony–Stimulating Factor Receptor Promotes Stem Cell Expansion, Monocytosis, and Atheroma Macrophage Burden in Mice With Hematopoietic ApoE Deficiency (2014) (75)
Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis (1995) (75)
Plasma cholesteryl ester transfer protein has binding sites for neutral lipids and phospholipids. (1988) (75)
Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque (2018) (75)
Anti-atherogenic mechanisms of high density lipoprotein: effects on myeloid cells. (2012) (75)
Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial. (2015) (74)
Exercise to reduce cardiovascular risk--how much is enough? (2002) (73)
Mitochondrial Oxidative Stress Promotes Atherosclerosis and Neutrophil Extracellular Traps in Aged Mice (2017) (72)
Foam cell-forming J774 macrophages have markedly elevated acyl coenzyme A:cholesterol acyl transferase activity compared with mouse peritoneal macrophages in the presence of low density lipoprotein (LDL) despite similar LDL receptor activity. (1987) (72)
Cdkn2a Is an Atherosclerosis Modifier Locus That Regulates Monocyte/Macrophage Proliferation (2011) (71)
Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques. (2019) (71)
From Lipids to Inflammation : New Approaches to Reducing Atherosclerotic Risk (2016) (70)
Inflammasomes, neutrophil extracellular traps, and cholesterol (2019) (70)
Is it time to modify the reverse cholesterol transport model? (2001) (69)
Pivotal Advance: Macrophages become resistant to cholesterol‐induced death after phagocytosis of apoptotic cells (2007) (69)
Rat intestine secretes spherical high density lipoproteins. (1983) (69)
Potential role of ABCA7 in cellular lipid efflux to apoA-I Published, JLR Papers in Press, November 1, 2004. DOI 10.1194/jlr.M400247-JLR200 (2005) (69)
Identification of a sequence within the C-terminal 26 amino acids of cholesteryl ester transfer protein responsible for binding a neutralizing monoclonal antibody and necessary for neutral lipid transfer activity. (1992) (69)
Human plasma cholesteryl ester transfer protein enhances the transfer of cholesteryl ester from high density lipoproteins into cultured HepG2 cells. (1987) (67)
Inhibition of acyl coenzyme A:cholesterol acyl transferase in J774 macrophages enhances down-regulation of the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl-coenzyme A reductase and prevents low density lipoprotein-induced cholesterol accumulation. (1986) (66)
Role of HDL , ABCA 1 , and ABCG 1 Transporters in Cholesterol Efflux and Immune Responses (2009) (66)
Stimulation of Vascular Smooth Muscle Cell Prostacyclin and Prostaglandin E2 Synthesis by Plasma High and Low Density Lipoproteins (1984) (65)
Familial cholesteryl ester transfer protein deficiency is associated with triglyceride-rich low density lipoproteins containing cholesteryl esters of probable intracellular origin. (1991) (64)
ApoA-II maintains HDL levels in part by inhibition of hepatic lipase. Studies In apoA-II and hepatic lipase double knockout mice. (1999) (64)
Disruption of Mammalian Target of Rapamycin Complex 1 in Macrophages Decreases Chemokine Gene Expression and Atherosclerosis (2014) (63)
Expanded Granulocyte/Monocyte Compartment in Myeloid-Specific Triple FoxO Knockout Increases Oxidative Stress and Accelerates Atherosclerosis in Mice (2013) (62)
Cholesterol efflux: a novel regulator of myelopoiesis and atherogenesis. (2012) (61)
Interaction of plasma high density lipoproteins with dimyristoyllecithin multilamellar liposomes. (1978) (61)
CAMKII&ggr; suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis (2017) (60)
Regulation of adrenal scavenger receptor-BI expression by ACTH and cellular cholesterol pools. (1999) (59)
Mild Renal Dysfunction and Metabolites Tied to Low HDL Cholesterol Are Associated With Monocytosis and Atherosclerosis (2013) (58)
Cholesteryl ester transfer protein activity enhances plasma cholesteryl ester formation. Studies in CETP transgenic mice and human genetic CETP deficiency. (1997) (58)
Facilitation of phosphatidylcholine transfer into high density lipoproteins by an apolipoprotein in the density 1.20-1.26 g/ml fraction of plasma. (1983) (58)
TTC39B Deficiency Stabilizes LXR Reducing both Atherosclerosis and Steatohepatitis (2016) (58)
Human Cholesteryl Ester Transfer Protein Gene Proximal Promoter Contains Dietary Cholesterol Positive Responsive Elements and Mediates Expression in Small Intestine and Periphery While Predominant Liver and Spleen Expression Is Controlled by 5′-distal Sequences (1996) (58)
Cholesteryl Ester Transfer Protein and Phospholipid Transfer Protein Have Nonoverlapping Functions in Vivo * (2000) (57)
Acute inhibition of hepatic lipase and increase in plasma lipoproteins after alcohol intake. (1984) (57)
Alternative splicing of the mRNA encoding the human cholesteryl ester transfer protein. (1992) (57)
LNK/SH2B3 Loss of Function Promotes Atherosclerosis and Thrombosis. (2016) (57)
TNFalpha induces ABCA1 through NF-kappaB in macrophages and in phagocytes ingesting apoptotic cells. (2006) (56)
Incorporation of phosphatidylcholine into spherical and discoidal lipoproteins during incubation of egg phosphatidylcholine vesicles with isolated high density lipoproteins or with plasma. (1981) (56)
Impaired MEK Signaling and SERCA Expression Promote ER Stress and Apoptosis in Insulin-Resistant Macrophages and Are Reversed by Exenatide Treatment (2012) (56)
Unusual high-density lipoprotein subclass distribution during late pregnancy. (1993) (54)
Studies on the transfer of phosphatidylcholine from unilamellar vesicles into plasma high density lipoproteins in the rat. (1980) (54)
Point mutagenesis of carboxyl-terminal amino acids of cholesteryl ester transfer protein. Opposite faces of an amphipathic helix important for cholesteryl ester transfer or for binding neutralizing antibody. (1993) (54)
Haplotypes of the cholesteryl ester transfer protein gene predict lipid-modifying response to statin therapy (2003) (54)
Probucol enhances selective uptake of HDL-associated cholesteryl esters in vitro by a scavenger receptor B-I-dependent mechanism. (1999) (54)
Role of apolipoprotein E-containing lipoproteins in abetalipoproteinemia. (1982) (53)
Cholesteryl ester transfer protein is secreted by Hep G2 cells and contains asparagine-linked carbohydrate and sialic acid. (1987) (53)
Microdomains, Inflammation, and Atherosclerosis (2016) (53)
Apolipoprotein CI Deficiency Markedly Augments Plasma Lipoprotein Changes Mediated by Human Cholesteryl Ester Transfer Protein (CETP) in CETP Transgenic/ApoCI-knocked Out Mice* (2002) (53)
Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice. (2002) (52)
SR-BI inhibits ABCG1-stimulated net cholesterol efflux from cells to plasma HDL Published, JLR Papers in Press, October 24, 2007. (2008) (51)
Receptors and Lipid Transfer Proteins in HDL Metabolism (2000) (50)
Perspectives for vascular genomics (2000) (50)
Thermal behavior of human plasma high density lipoprotein. (1977) (48)
Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency (2001) (48)
Characterization of the lipoproteins of atherosclerotic swine. (1977) (48)
Metabolic and genetic control of HDL cholesterol levels (1992) (48)
Cholesterol Efflux Pathways Regulate Myelopoiesis: A Potential Link to Altered Macrophage Function in Atherosclerosis (2014) (48)
LXR Suppresses Inflammatory Gene Expression and Neutrophil Migration through cis-Repression and Cholesterol Efflux (2018) (48)
HDL and Glut1 inhibition reverse a hypermetabolic state in mouse models of myeloproliferative disorders (2013) (47)
Interaction of cholesterol, phospholipid and apoprotein in high density lipoprotein recombinants. (1978) (46)
Profound induction of hepatic cholesteryl ester transfer protein transgene expression in apolipoprotein E and low density lipoprotein receptor gene knockout mice. A novel mechanism signals changes in plasma cholesterol levels. (1996) (46)
Apoprotein stability and lipid-protein interactions in human plasma high density lipoproteins. (1975) (45)
Increased Systemic and Plaque Inflammation in ABCA1 Mutation Carriers With Attenuation by Statins (2015) (45)
Human plasma cholesteryl ester transfer protein consists of a mixture of two forms reflecting variable glycosylation at asparagine 341. (1993) (45)
Adipose tissue cholesteryl ester transfer protein mRNA in response to probucol treatment: cholesterol and species dependence. (1993) (44)
Role of ABCA1 in cellular cholesterol efflux and reverse cholesterol transport. (2003) (44)
Plasma high density lipoproteins: Therapeutic targeting and links to atherogenic inflammation. (2018) (44)
Defective Binding of Neutral Lipids by a Carboxyl-terminal Deletion Mutant of Cholesteryl Ester Transfer Protein (1995) (43)
The CCAAT/enhancer-binding protein trans-activates the human cholesteryl ester transfer protein gene promoter. (1992) (43)
Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI. (1995) (43)
Pegylation of High-Density Lipoprotein Decreases Plasma Clearance and Enhances Antiatherogenic Activity (2013) (43)
HDL proteomics: pot of gold or Pandora's box? (2007) (42)
Quantitative Trait Locus Mapping of Genetic Modifiers of Metabolic Syndrome and Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice: Identification of a Locus for Metabolic Syndrome and Increased Atherosclerosis on Chromosome 4 (2004) (42)
Cholesteryl ester transfer protein modulates the effect of liver X receptor agonists on cholesterol transport and excretion in the mouse Published, JLR Papers in Press, December 16, 2003. DOI 10.1194/jlr.M300432-JLR200 (2004) (42)
MIghty mouse. (2002) (40)
Sterol Regulatory Element Binding Protein-1 Activates the Cholesteryl Ester Transfer Protein Gene in Vivobut Is Not Required for Sterol Up-regulation of Gene Expression* (1998) (40)
Interaction of cholesterol ester and triglyceride in human plasma very low density lipoprotein. (1977) (39)
Effect of biliary diversion on rat mesenteric lymph apolipoprotein-I and high density lipoprotein. (1982) (39)
IFN- g Potentiates Atherosclerosis in ApoE Knock-out Mice (1997) (38)
Intralipid Infusion Abolishes Ability of Human Serum to Cholesterol‐load Cultured Macrophages (1989) (38)
Protease variants, LDL, and coronary heart disease. (2006) (37)
Efflux and Atherosclerosis The Clinical and Biochemical Impact of Variations in the ABCA1 Gene (2003) (37)
The effects of cholesterol ester transfer protein inhibition on cholesterol efflux. (2009) (37)
Interaction of collagen with the lipids of tendon xanthomata. (1978) (37)
Spontaneous Atherothrombosis and Medial Degradation in Apoe−/−, Npc1−/− Mice (2007) (37)
Adipose tissue-specific CETP expression in mice: impact on plasma lipoprotein metabolism Published, JLR Papers in Press, June 2, 2006. (2006) (36)
The effect of chronic cholesterol feeding on intestinal lipoproteins in the rat. (1980) (36)
Interfacial properties of recombinant human cholesterol ester transfer protein. (1994) (36)
TLR3 deficiency protects against collagen degradation and medial destruction in murine atherosclerotic plaques. (2013) (35)
Phospholipid liposomes acquire apolipoprotein E in atherogenic plasma and block cholesterol loading of cultured macrophages. (1987) (34)
Point mutagenesis of positively charged amino acids of cholesteryl ester transfer protein: conserved residues within the lipid transfer/lipopolysaccharide binding protein gene family essential for function. (1995) (33)
Alternative Splicing of the Human Cholesteryl Ester Transfer Protein Gene in Transgenic Mice (1996) (32)
Gender effects on the distribution of the cholesteryl ester transfer protein in apolipoprotein A-I-defined lipoprotein subpopulations. (1994) (32)
n-3 fatty acids ameliorate hepatic steatosis and dysfunction after LXR agonist ingestion in mice. (2011) (32)
Athsq1 Is an Atherosclerosis Modifier Locus With Dramatic Effects on Lesion Area and Prominent Accumulation of Versican (2008) (32)
Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein (2021) (31)
Inhibition of the cellular secretion of cholesteryl ester transfer protein by a variant protein formed by alternative splicing of mRNA. (1993) (31)
Structure-function studies of human cholesteryl ester transfer protein by linker insertion scanning mutagenesis. (1991) (30)
Cholesterol efflux pathways, inflammation, and atherosclerosis (2021) (30)
Incorporation of cholesterol into high density lipoprotein recombinants. (1978) (29)
Plasma kinetics of cholesteryl ester transfer protein in the rabbit. Effects of dietary cholesterol. (1997) (29)
Sorting out sortilin. (2011) (29)
Plasma enzymes and transfer proteins in cholesterol metabolism (1990) (28)
Plasma metabolite profiles, cellular cholesterol efflux, and non-traditional cardiovascular risk in patients with CKD. (2017) (28)
Inhibition of JAK2 Suppresses Myelopoiesis and Atherosclerosis in Apoe−/− Mice (2020) (28)
Increased Atherosclerosis in Mice With Vascular ATP-Binding Cassette Transporter G1 Deficiency—Brief Report (2010) (28)
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease (2016) (28)
Inhibition of cholesteryl ester transfer protein by substituted dithiobisnicotinic acid dimethyl ester: involvement Of a critical cysteine. (2000) (27)
Metformin and AMP Kinase Activation Increase Expression of the Sterol Transporters ABCG5/8 (ATP-Binding Cassette Transporter G5/G8) With Potential Antiatherogenic Consequences (2018) (27)
STUDIES IN CHYLURIC SUBJECTS (1979) (27)
Metabolism of postprandial lipoproteins. (1986) (26)
Recognition of vesicular lipoproteins by the apolipoprotein B,E receptor of cultured fibroblasts. (1986) (26)
Effect of a neutralizing monoclonal antibody to cholesteryl ester transfer protein on the redistribution of apolipoproteins A-IV and E among human lipoproteins. (1989) (24)
Interaction of diet and genes in atherogenesis. Report of an NHLBI working group. (1997) (24)
Functions of cholesterol ester transfer protein and relationship to coronary artery disease risk. (2010) (24)
The Success Story of LDL Cholesterol Lowering (2016) (24)
Structural organization of the lipoprotein HDLc from atherosclerotic swine. Structural features relating the particle surface and core. (1978) (24)
Deletion of ABCA 1 and ABCG 1 Impairs Macrophage Migration Because of Increased Rac 1 Signaling (2011) (22)
Proliferating macrophages populate established atherosclerotic lesions. (2014) (22)
Increasing Lipolysis and Reducing Atherosclerosis. (2017) (22)
Structure-function relationships of human cholesteryl ester transfer protein: analysis using monoclonal antibodies. (1996) (22)
Macrophages Use Apoptotic Cell-Derived Methionine and DNMT3A During Efferocytosis to Promote Tissue Resolution (2022) (21)
Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle Metabolism (2016) (21)
Addressing dyslipidemic risk beyond LDL-cholesterol (2022) (20)
[37] Lipoprotein-liposome interactions (1986) (19)
Drugs, alcohol and malabsorption. (1979) (19)
Structure-function analysis of plasma cholesteryl ester transfer protein by protease digestion and expression of cDNA fragments in Escherichia coli. (1989) (18)
Interfacial Exclusion Pressure Determines the Ability of Apolipoprotein A-IV Truncation Mutants to Activate Cholesterol Ester Transfer Protein* (2002) (17)
Lipid and metabolic syndrome traits in coronary artery disease: a Mendelian randomization study (2020) (17)
Homozygosity for an Allele Encoding Deacetylated FoxO1 Protects Macrophages From Cholesterol-Induced Inflammation Without Increasing Apoptosis (2011) (17)
Incorporation of radioactive phospholipid into subclasses of high-density lipoproteins. (1983) (17)
Cardiovascular disease: Commonality with cancer (2017) (17)
Cholesteryl Ester Transfer Protein and Atherogenesis (1997) (16)
How broken sleep promotes cardiovascular disease (2019) (16)
Liver X receptors are required for thymic resilience and T cell output (2020) (16)
‘Orphans’ meet cholesterol (2000) (16)
Lipid Transfer Proteins , HDL Metabolism , and Atherogenesis (2000) (16)
SORTILIN: many headed hydra. (2015) (15)
Oxidized Phospholipids Promote NETosis and Arterial Thrombosis in LNK(SH2B3) Deficiency (2021) (15)
PPARγ Deacetylation Confers the Antiatherogenic Effect and Improves Endothelial Function in Diabetes Treatment (2020) (15)
Myeloid-specific genetic ablation of ATP-binding cassette transporter ABCA1 is protective against cancer (2017) (15)
Phospholipid transfer protein and atherosclerosis. (2003) (15)
Myeloid LXR (Liver X Receptor) Deficiency Induces Inflammatory Gene Expression in Foamy Macrophages and Accelerates Atherosclerosis (2022) (14)
Association of High‐Density Lipoprotein‐Cholesterol Versus Apolipoprotein A‐I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer‐Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study (2017) (13)
ABCA1 Exerts Tumor-Suppressor Function in Myeloproliferative Neoplasms (2020) (13)
Reduced VLDL clearance in Apoe−/−Npc1−/− mice is associated with increased Pcsk9 and Idol expression and decreased hepatic LDL-receptor levels (2010) (13)
STRUCTURE OF PLASMA LIPOPROTEINS: VIEW FROM CALORIMETRIC STUDIES * (1980) (13)
Increased High Density Lipoprotein (HDL), Defective Hepatic Catabolism of ApoA-I and ApoA-II, and Decreased ApoA-I mRNA inob/ob Mice (1999) (13)
Enhanced Megakaryopoiesis and Platelet Activity in Hypercholesterolemic, B6-Ldlr −/−, Cdkn2a-Deficient Mice (2016) (12)
Myeloid-specific genetic ablation of ATP-binding cassette transporter ABCA1 is protective against cancer. (2017) (12)
Antisense oligonucleotide treatment produces a type I interferon response that protects against diet-induced obesity (2020) (12)
The impact of insulin resistance on macrophage death pathways in advanced atherosclerosis. (2007) (10)
Organization of the core lipids of high density lipoproteins in the lactating bovine. (1981) (10)
Clonal hematopoiesis in cardiovascular disease and therapeutic implications (2022) (10)
Erythroid lineage Jak2V617F expression promotes atherosclerosis through erythrophagocytosis and macrophage ferroptosis (2022) (9)
Chapter 9 Mechanisms of facilitated lipid transfer mediated by plasma lipid transfer proteins (1987) (9)
From Lipids to Inflammation (2016) (8)
A New Approach to PCSK9 Therapeutics. (2017) (8)
Absence of liquid crystalline transitions of cholesterol esters in reconstituted low density lipoproteins (1979) (8)
High-Density Lipoproteins, Endothelial Function, and Mendelian Randomization. (2016) (8)
Expression of LXR target genes decreases cellular amyloid β peptide secretion (2003) (7)
Cholesterol mass efflux capacity and risk of peripheral artery disease: The Multi-Ethnic Study of Atherosclerosis. (2020) (7)
Macrophage‐Specific Expression of Human Collagenase (MMP‐1) in Transgenic Mice (1999) (7)
A PEST sequence in ABCA 1 regulates degradation by calpain protease and stabilization of ABCA 1 by apoA-I (2018) (7)
HDL in Morbidity and Mortality: A 40+ Year Perspective. (2020) (6)
Cell Surface Localization of ABCG1 Does Not Require LXR Activation (2006) (6)
Lipoprotein-liposome interactions. (1986) (6)
A new pathway of macrophage cholesterol efflux (2020) (5)
Macular Degeneration and CETP Inhibition. (2022) (5)
High density lipoproteins provide arachidonate for endothelial cell prostacyclin synthesis. (1984) (4)
Lipid and metabolic syndrome traits in coronary artery disease: a Mendelian randomization study. (2021) (4)
of ABCA 1 in Macrophages Retinoic Acid Receptor-Mediated Induction (2003) (4)
Effects of high-density lipoprotein and the apoprotein of high-density lipoprotein on prostacyclin synthesis by endothelial cells. (1983) (4)
Leducq Transatlantic Network on Clonal Hematopoiesis and Atherosclerosis. (2019) (3)
Cholesterol efflux potential of sera from mice expressing human CETP and/or human apo A-I (1994) (3)
Cholesteryl ester transfer protein inhibition: a dysfunctional endothelium. (2010) (3)
Abstract 1184: Hdl Protects Macrophages From Oxidized Ldl-induced Apoptosis By Promoting Efflux Of 7-ketocholesterol Via Abcg1 (2007) (3)
A, B, C…γ! (2000) (3)
A Biophysical Approach to Cholesterol Transport from Tissues to Bile (1979) (2)
Response by Fotakis et al to Letter Regarding Article, "Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques". (2020) (2)
Title : Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming (2016) (2)
Prospects and Future Challenges Translation of High-Density Lipoprotein Function Into Clinical Practice: Current (2013) (2)
Contemporary Reviews in Cardiovascular Medicine Cholesterol Efflux and Atheroprotection Advancing the Concept of Reverse Cholesterol Transport (2012) (2)
Cholesteryl ester transfer protein and phospholipid transfer protein have non-overlapping functions in vivo (2000) (1)
High density lipoproteins and atherosclerosis III : proceedings of the 3rd International Symposium on Plasma High Density Lipoproteins and Atherosclerosis, San Antonio, 4-6 March 1992 (1992) (1)
LES CORPS ETRANGERS DE L'ŒSOPHAGE A propos de 212 cas (2009) (1)
Regulation of Hematopoiesis by Cholesterol (2014) (1)
Abstract: S3-34 ROLE OF ABCA1 AND ABCG1 IN ATHEROGENESIS (2009) (1)
Tu-W23:1 ABC transporters, lipid efflux and atherosclerosis (2006) (1)
In Memoriam: Donald MacFarland Small (1931–2019) (2019) (1)
Therapeutic modulation of cellular cholesterol efflux (2001) (1)
Foreign bodies of the oesophagus: a review of 213 cases. (2009) (1)
Abstract 5816: The Human Apoa-1 Transgene Suppresses Myeloid Proliferation and Accelerated Atherosclerosis in Ldlr Deficient Mice Reconstituted With ABC Transporter Deficient Bone Marrow (2009) (1)
Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of HDL-cholesterol in a general Japanese population (1994) (1)
Abstract 551: The Dual Effect of Cigarette Smoke on Macrophage Abca1-dependent Cholesterol Efflux and Protease Production Leads to Decreased Collagen and Increased Necrosis in Plaques of ApoE Deficient Mice (2013) (1)
3911Impact of CETP inhibition with evacetrapib in patients with diabetes mellitus: results from ACCELERATE (2017) (1)
JAK2V617F Promotes Atherosclerosis (2016) (1)
SHORT TERM TRAINING DECREASES PLASMA CHOLESTERYL ESTER TRANSFER PROTEIN 168 (1996) (1)
TTC39B deficiency promotes HDL production and impairs non-hdl absorption in small intestine (2014) (1)
P5355Impact of evacetrapib on glyvemic control: results from the accelerate trial (2017) (1)
7. Lipid transfer proteins and receptors in HDL metabolism (1999) (1)
Plasma lipids in extra hepatic biliary obstruction. (1975) (1)
Abstract 19263: Enhancing Cholesterol Efflux Pathways Suppresses Hematopoietic Stem Cell Proliferation and Monocytosis in apoE−/− Mice (2010) (1)
Plasma lipoprotein phenotype in response to cholesteryl ester transfer protein levels in dyslipoproteinemia. (1991) (1)
The J774 Macrophage Model of Native LDL-Induced Foam Cell Formation (1987) (1)
The Failure of Torcetrapib (2007) (1)
Abstract: 1445 TREATMENT STRATEGIES TO ENHANCE REVERSE CHOLESTEROL TRANSPORT (2009) (1)
Products of delipidation of intestinal chylomicrons with diethyl ether. (1980) (0)
CETP Inhibition: a Dysfunctional Endothelium? (2010) (0)
Place de l'aryténoïdopexie dans les paralysies récurrentielles post-thyroïdectomie en adduction : à propos de 14 cas (2001) (0)
Abstract 405: Deficiency of p38{alpha} MAPK in Macrophages Promotes Apoptosis and Plaque Necrosis in Advanced Murine Atherosclerotic Lesions (2008) (0)
Abstract 56: Macrophage Reverse Cholesterol Transport in Mice Relies on The Lymphatic Vasculature (2013) (0)
Molecular Genetics of Plasma Lipid Transfer Proteins (1993) (0)
Abstract 040: Accelerated Atherosclerosis and Thrombosis in Jak2v617f Mice (2018) (0)
3FS06-1 Regulation of macrophage cholesterol efflux (2003) (0)
University of Groningen Myeloid-specific genetic ablation of ATP-binding cassette transporter ABCA1 is protective against cancer Zamanian-Daryoush, (2017) (0)
Abstract 64: Pancreatic ß-Cell--Specific Deletion of ABCA1 and ABCG1 Perturbs Glucose Metabolism and Increases Adiposity in Mice (2014) (0)
A new fluorescent assay for CETP activity using a pyrene-labeled cholesteryl ester incorporated into phospholipid/apo A-I discoidal complexes (1994) (0)
Thyroid hormones increase HDL catabolism and plasma cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice (1999) (0)
FoxOs promote apoptosis of insulin resistant macrophages during cholesterol-induced ER stress (2008) (0)
Plasma sphingomyelin in subclinical atherosclerosis: findings from the multi-ethic study of atherosclerosis (2007) (0)
Clonal hematopoiesis and ischemic stroke. (2023) (0)
Feinberg and Moore MicroRNA Regulation of Atherosclerosis 705 (2016) (0)
CHOLESTEROL EFFLUX PATHWAYS SUPPRESS INFLAMMASOME ACTIVATION, NEUTROPHIL EXTRACELLULAR TRAP FORMATION, AND ATHEROSCLEROSIS (2018) (0)
Results Suppression of Myeloid Cell mitoOS Protects Against Atherosclerosis and Reduces Myeloid Cell Accumulation in Aged Mice (2017) (0)
Cholesterol accumulation in macrophages drives NETosis in atherosclerotic plaques via IL-1β secretion (2022) (0)
Abstract 143: Il-1β Antagonism Promotes SMC Differentiation And Accumulation In Fibrous Caps In Jak2 V617f Clonal Hematopoiesis (2022) (0)
Abstract 17: Reverse Cholesterol Transport Relies on a Functional Lymphatic Network (2012) (0)
Human ApoA-I1 Inhibits the Hydrolysis of HDL Triglyceride and the Decrease of HDL Size Induced by Hypertriglyceridemia and Cholesteryl Ester Transfer Protein in Transgenic Mice (0)
Abstract 16198: Ttc39b Deficiency Causes an Intestinal Lxr Activation Phenotype With Increased Expression Of Abca1 and HDL-Cholesterol Levels (2013) (0)
Abstract 62: Cholesterol Efflux Pathways in Dendritic Cells Suppress Autoimmune Responses (2014) (0)
MicroRNA Regulation of Atherosclerosis (2016) (0)
Human ApoA-I 1 Inhibits the Hydrolysis of HDL Triglyceride and the Decrease of HDL Size Induced by Hypertriglyceridemia and Cholesteryl Ester Transfer Protein in Transgenic Mice (2013) (0)
Induction of the plasma phospholipid transfer protein (PLTP) gene accounts for the HDL enlargement in mice treated with fenofibrate. Lack of HDL size redistribution in treated PLTP-deficient mice (2001) (0)
In Memoriam: Donald MacFarland Small (1931-2019). (2019) (0)
Cholesterol ester transfer protein. Characterization of monoclonal antibodies against the human antigen. (1988) (0)
ABCA1, ABCG1 and the Athero‐protective Effects of HDL (2008) (0)
2.W17.5 Genetic determinants of HDL and their relationships to atherosclerosis (1997) (0)
Genetic modification of inflammation and clonal hematopoiesis-associated coronary artery disease (2022) (0)
Pancreatic beta-cell specific deletion of ABCA1 and ABCG1 perturbs glucose metabolism and increases adiposity in mice due to suboptimal plasma insulin levels (2015) (0)
Abstract 16836: Ttc39b Deficiency Attenuates Atherosclerosis and Hepatic Steatosis Through Lxrα Dependent Manner (2016) (0)
High-Risk Lipid Phenotype and Incidence of Coronary Heart Disease and Ischemic Stroke and Cardiovascular Mortality Risk Stratified by Monocyte Count (MS1872) (2011) (0)
CETP , Lipoprotein Metabolism , and Atherosclerosis in Humans Genetic CETP Deficiency in Humans and Effects on Lipoprotein Metabolism (2003) (0)
Abstract 14857: Hepatic Insulin Signaling Posttranscriptionally Regulates Ldl Receptor via Pcsk9 (2010) (0)
Donald MacFarland Small, MD, MA (Oxon) (2019) (0)
The development of CETP (cholesteryl Trials and Tribulations of CETP Inhibitors (2017) (0)
Cholesterol mass efflux capacity and coronary artery calcium: The multi-ethnic study of atherosclerosis. (2022) (0)
Abstract 523: Regulation of Pancreatic β-cell Gene Expression and Function by ABCA1 and ABCG1 (2015) (0)
Properties of ApoA-I Milano (2005) (0)
Abstract 421: Hematopoietic Deficiency In NLRP3 And AIM2 Inflammasomes Or Gasdermin D Fails To Prevent Atherosclerosis Progression In Mouse Models Of Diabetes (2022) (0)
Abstract 10658: Activation of the Liver X Receptor Decreases Atherosclerosis in LDLr-/- Mice in the Absence of ATP-Binding Cassette Transporters A1 and G1 in Myeloid Cells (2011) (0)
[Management of recurrent post thyroidectomy abductor vocal cord paralysis at the Ear, Nose and Throat (ENT) department of the Dakar University Teaching Hospital: report of 14 cases]. (2002) (0)
AIMing 2 treat atherosclerosis (2022) (0)
RCT and the inflammatory response The acute phase response inhibits (2015) (0)
RoleofApolipoprotein E-containing Lipoproteins inAbetalipoprotein emia (1982) (0)
Genetics of Coronary Artery Disease (2016) (0)
hange in Lipid Profile in Celiac Disease : Beneficial ffect of Gluten-Free Diet (2006) (0)
Treatment of and screening for hyperlipidemia. (1993) (0)
Role of ABCA 1 and ABCG 1 in Atherogenesis (2010) (0)
Hematopoietic Stem Cell Expansion Leads to Monocytosis In Animal Models of Atherosclerosis (2010) (0)
Abstract 20416: Ttc39b Deficiency Has a Beneficial Role on Cholesterol and Triglyceride Absorption in Enterocytes (2014) (0)
How broken sleep promotes cardiovascular disease (2019) (0)
Abstract 1338: Decreased Atherosclerosis in LDL Receptor Knock-out Mice Transplanted with ABCG1 Deficient Bone Marrow is Associated with Compensatory Induction of Abca1 and apoE Secretion from Macrophages (2006) (0)
The Role ABCG1 in Cellular Cholesterol Efflux: Relevance to Atherosclerosis and Endothelial Function (2010) (0)
Cell Stem Cell ABCA 1 , ABCG 1 , and HDL Regulate HSPC (0)
Lipid Transport by Apolipoprotein AI: Structure and Function (1993) (0)
Erratum. Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle Metabolism. Diabetes 2016;65:3610–3620 (2016) (0)
New insights into cholesterol efflux via ABCA1 (2022) (0)
Hematopoietic NLRP3 and AIM2 inflammasomes promote diabetes-accelerated atherosclerosis, but increased necrosis is independent of pyroptosis. (2023) (0)
SH2B3/LNK Loss of Function Promotes Atherosclerosis and Thrombosis (2015) (0)
Abstract 43: Cholesterol Efflux Pathways Suppress Inflammasome Activation in Mice and Humans (2017) (0)
Role of CETP in the Development of Atherosclerosis in Animals Expression of CETP in Transgenic Mice (2003) (0)
The role of TTC39B in atherosclerosis and non-alcoholic steatohepatitis. (2017) (0)
TTC39B destabilizes retinoblastoma protein promoting hepatic lipogenesis in a sex-specific fashion. (2021) (0)
HDL and ABC Transporters Reduce the Proliferation of Hematopoietic Stem and Progenitor Cells, with Anti-atherogenic Consequences (2011) (0)
CETP expression increases HDL cholesteryl ester tissue uptake and plasma fractional catabolic rate in transgenic mice (1999) (0)
Supplementary Material (nature09270-s1) (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Alan Richard Tall?

Alan Richard Tall is affiliated with the following schools:

Alan Richard Tall's Academic­Influence.com Rankings

Alan Richard Tall's Degrees

Why Is Alan Richard Tall Influential?

Alan Richard Tall's Published Works

Published Works

What Schools Are Affiliated With Alan Richard Tall?

Alan Richard Tall's AcademicInfluence.com Rankings